AI주식인사이트AI Stock Insight
C

케이엠제약

225430KOSDAQ기타 화학제품 제조업

50.7 / 100

Reference Date: 2026-04-13

Financial Score11.5 / 40
News Sentiment14.2 / 25
Momentum15.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but the high debt ratio poses financial risk. Surged 35.4% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

KEM Pharmaceuticals specializes in oral care, beauty care, and daily necessities, offering a wide range of products such as children's and adult toothpaste, shampoo, body wash, and anti-wrinkle skincare. Its flagship brands, 'Pororo Friends' and 'Kkoma Bus Taeyo,' account for approximately 33.4% of sales, with active OEM/ODM business. The company aims to expand its domestic and international distribution channels and grow into a comprehensive daily necessities company by maintaining high-quality products.

Number of Employees

63people

Average Salary

42.8M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 18.384.0Point
PBR
0.54Industry Average 1.377.0Point

Half of industry avg (excellent)

ROE
-13.04Industry Average 4.550.0Point

Well below industry avg

Debt Ratio
22.04Industry Average 8.130.0Point

2.7x industry avg (risky)

Trend 2023~20250.5 / 10 points
Revenue Growth Rate
0.5 / 3

Avg ▼4.0% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼74.7% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -10.0% (declining, 3yr)

Detailed News Sentiment

9 totalPositive 2Neutral 2Negative 0Average Sentiment Score 65

Detailed Momentum

52-week position3.0Point

52w lower range (29%)

Current 551Won52-week high 1,05452-week low 340
1-month return6.0Point

1m +35.38% (strong rise)

Volume trend6.0Point

Volume surge

Detailed Disclosure

14 totalPositive 0Neutral 14Negative 0
  • Neutral주권매매거래정지 (주식의 병합, 분할 등 전자등록 변경, 말소)2026-04-09
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-09
  • Neutral주식등의대량보유상황보고서(일반)2026-04-09
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-09
  • Neutral대표이사변경2026-03-31